This study about AI discovering a new antibiotic against resistant bacteria is getting a lot of press
Anyone with domain expertise know how real/significant this is?
“Deep learning-guided discovery of an antibiotic targeting *Acinetobacter baumannii*”
nature.com/articles/s4158
Conversation
Because it’s not just “apply chemical X on target Y for effect Z”. It’s developing a new compound & hoping it has a particular effect in an incredibly complex system. Think of it like an optimization problem, not a password to be cracked for which a rainbow table already exists.
19
This paper is so cool!!!!
More legit than Halicin, but not what I would describe as a full active/in-silico system...
... Abaucin is a previously investigated compound that was flagged for inhibition potential by the active learning system in this paper...
1
8
Show replies
The problem with antibiotic drug discovery is that it is unprofitable. There have been many, many exciting molecules developed at the laboratory/pre-clinical stage over the past 30 years. They are not brought to market because it is unprofitable to do so.
2
2
6
Example 9 billion of why calls for a moratorium on AI development are asinine
2










